American Journal of Kidney Diseases
Volume 52, Issue 1 , Pages 29-38, July 2008

Waist-to-Hip Ratio, Body Mass Index, and Subsequent Kidney Disease and Death

  • Essam F. Elsayed, MD, MS

      Affiliations

    • Nephrology Research Center, Tufts-New England Medical Center, Boston, MA
  • ,
  • Mark J. Sarnak, MD, MS

      Affiliations

    • Nephrology Research Center, Tufts-New England Medical Center, Boston, MA
  • ,
  • Hocine Tighiouart, MS

      Affiliations

    • Biostatistics Research Center, Tufts-New England Medical Center, Boston, MA
  • ,
  • John L. Griffith, PhD

      Affiliations

    • Biostatistics Research Center, Tufts-New England Medical Center, Boston, MA
  • ,
  • Tobias Kurth, MD, ScD

      Affiliations

    • Preventive Medicine, Brigham and Women's Hospital, Boston, MA
  • ,
  • Deeb N. Salem, MD

      Affiliations

    • Division of Cardiology, Tufts-New England Medical Center, Boston, MA.
  • ,
  • Andrew S. Levey, MD

      Affiliations

    • Nephrology Research Center, Tufts-New England Medical Center, Boston, MA
  • ,
  • Daniel E. Weiner, MD, MS

      Affiliations

    • Nephrology Research Center, Tufts-New England Medical Center, Boston, MA
    • Corresponding Author InformationAddress correspondence to Daniel E. Weiner, MD, MS, Division of Nephrology, Box #391, Tufts Medical Center, Boston, MA 02111.

Received 31 December 2007; accepted 25 February 2008. published online 30 May 2008.

Background

Chronic kidney disease (CKD) and obesity are important public health concerns. We examined the association between anthropomorphic measures and incident CKD and mortality.

Study Design

Cohort study.

Setting & Participants

Individual patient data pooled from the Atherosclerosis Risk in Communities Study and the Cardiovascular Health Study.

Predictors

Waist-to-hip ratio (WHR), body mass index (BMI).

Outcomes & Measurements

Incident CKD defined as serum creatinine level increase greater than 0.4 mg/dL with baseline creatinine level of 1.4 mg/dL or less in men and 1.2 mg/dL or less in women and final creatinine level greater than these levels, and, in separate analyses, estimated glomerular filtration rate (eGFR) decrease of 15 mL/min/1.73 m2 or greater with baseline eGFR of 60 mL/min/1.73 m2 or greater and final eGFR less than 60 mL/min/1.73 m2. Multivariable logistic regression to determine the association between WHR, BMI, and outcomes. Cox models to evaluate a secondary composite outcome of all-cause mortality and incident CKD.

Results

Of 13,324 individuals, mean WHR was 0.96 in men and 0.89 in women and mean BMI was 27.2 kg/m2 in both men and women. During 9.3 years, 300 patients (2.3%) in creatinine-based models and 710 patients (5.5%) in eGFR-based models developed CKD. In creatinine-based models, each SD increase in WHR was associated with increased risk of incident CKD (odds ratio, 1.22; 95% confidence interval [CI], 1.05 to 1.43) and the composite outcome (hazard ratio, 1.12; 95% CI, 1.06 to 1.18), whereas each SD increase in BMI was not associated with CKD (odds ratio, 1.05; 95% CI, 0.93 to 1.20) and appeared protective for the composite outcome (hazard ratio, 0.94; 95% CI, 0.90 to 0.99). Results of eGFR-based models were similar.

Limitations

Single measures of creatinine, no albuminuria data.

Conclusions

WHR, but not BMI, is associated with incident CKD and mortality. Assessment of CKD risk should use WHR rather than BMI as an anthropomorphic measure of obesity.

Index Words: Obesity, kidney disease, body mass index, waist-to-hip ratio, mortality

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Because an author of this manuscript is an editor for AJKD, the peer-review and decision-making processes were handled entirely by an Associate Editor (Katherine Tuttle, MD, Sacred Heart Medical Center) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

 Originally published online as doi:10.1053/j.ajkd.2008.02.363 on May 30, 2008.

PII: S0272-6386(08)00741-5

doi:10.1053/j.ajkd.2008.02.363

American Journal of Kidney Diseases
Volume 52, Issue 1 , Pages 29-38, July 2008